BDC Symposium focused on Canadian/US Bio Industry

The Biorenewable Deployment Consortium (BDC) Fall Symposium was held in Ottawa, Ontario in September and was combined with a site visit to Ensyn’s production facility in Renfrew, just outside of Ottawa.

The Symposium had record attendance including a diverse group of international members and guests. Discussions included updates from leading cellulosic bioproducts companies as well as presentations from relevant Canadian and US Government agencies. Highlights included:

• Keynote by Jonathan Male, Director of Bioenergy Technologies for US DOE regarding opportunities in a changing energy landscape.

• Presentation by Otavio Pontes, Vice President, Latin America Division of Stora Enso Biomaterials on extracting additional value from Biomass.

• Panel on Regulatory Pathways, which included Paul Argyropoulos, Senior Policy Adviser, EPA; Todd Campbell, Energy & Bioeconomy Policy Advisor, USDA; Elliot Levine, Technology Manager, US DOE; Jean-Francois Levasseur, IFIT Program Leader, Natural Resources Canada; and private industry representatives.

• Commercial Progress updates provided by Licella (Commercial Project to convert biomass and lignite to bio-crude oil and chemicals in Australia and working toward a North American commercial project), Borregaard/LignoTech (Lignin Joint Venture planned for North America), West Fraser (Start-up of LignoForce lignin extraction plant in Hinton, AB), Green Biologics (Repurposing Minnesota ethanol plant to n-butanol), TRI/Fulcrum (MSW to jet fuel project in Nevada), and Ensyn (Commercial plant in Renfrew, Ontario and new projects in Brazil, Canada and the US).

• Success Story by Dr. Robert Graham, CEO and founder of Ensyn, who had the vision in 1984 to establish the company with a specific focus on the production of high value products through fast thermal conversion of carbon-based feedstocks. Dr. Graham presented the history of Ensyn, starting from the theoretical foundation of Ensyn’s Rapid Thermal Processing (RTP®) technology, through the early commercialization of the technology in food chemicals and heating fuels and to the current build out of production capacity for a broader commercialization of heating fuels and for the introduction of refinery co-processing. With more than 40 million gallons of historical production, Ensyn is now embarking on an ambitious buildout of capacity for the fuels business, starting with its existing 3 million gallon/year facility in Renfrew, Ontario, and new commercial projects under development in Brazil and North America. Ensyn has approved existing pathways under the RFS program for heating and refinery co-processing applications for its key product known as RFO. Ensyn is currently generating RINs from commercial RFO heating contracts in Northeastern US. Ensyn is executing its business plan by working closely with several industry leaders including Honeywell UOP, Fibria Celulose and Chevron Technology Ventures.

• Tour of the 3 million gallon/year Ensyn facility in Renfrew. This commercial facility was commissioned in 2006 as a merchant plant for the chemicals and heating fuels business and was enhanced in 2014 as a dedicated fuels production facility to meet market demand for heating oil in Northeast United States and Canada and for commercialization of refinery applications.

BDC’s mission is to help deploy economic bioprocesses—operations that will be economic successes without government subsidy long-term. In addition to its efforts to broker partnerships for deployment projects, BDC holds two symposiums each year to provide education in areas that its membership has interest and includes a related tour of a leading edge bio-facility.

BDC’s membership is made up of forestry, pulp & paper, and bioprocess companies, and is well attended by government agencies. The diverse make-up of the membership and environment of the meetings lead to good and honest discussion that is helpful in accelerating the bio-industry progress.

For more information contact Ben Thorp at: Ben.Thorp@biorenewabledc.org; Harry Seamans at: Harry.Seamans@biorenewabledc.org; or Ian Barnett, Ensyn EVP at: ibarnett@ensyn.com.

Now that you are Ahead of the Curve, stay there by joining TAPPI.
For a modest investment of $174, receive more than US$ 1000 in benefits in return.
Visit www.tappi.org/join for more details.